1. Home
  2. ASC vs KALV Comparison

ASC vs KALV Comparison

Compare ASC & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardmore Shipping Corporation

ASC

Ardmore Shipping Corporation

HOLD

Current Price

$15.98

Market Cap

683.9M

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$26.80

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASC
KALV
Founded
2010
N/A
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
683.9M
1.0B
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
ASC
KALV
Price
$15.98
$26.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$17.00
$32.60
AVG Volume (30 Days)
713.6K
3.9M
Earning Date
05-07-2026
07-09-2026
Dividend Yield
1.74%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$50,000,000.00
Revenue This Year
N/A
$185.42
Revenue Next Year
N/A
$59.23
P/E Ratio
$16.60
N/A
Revenue Growth
N/A
495.66
52 Week Low
$9.18
$9.83
52 Week High
$20.03
$26.85

Technical Indicators

Market Signals
Indicator
ASC
KALV
Relative Strength Index (RSI) 34.47 74.29
Support Level $14.91 $14.22
Resistance Level $16.91 $26.85
Average True Range (ATR) 0.73 0.06
MACD -0.43 -0.28
Stochastic Oscillator 6.64 76.47

Price Performance

Historical Comparison
ASC
KALV

About ASC Ardmore Shipping Corporation

Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The company markets its services directly to its customers and commercial pool operators and charters its vessels to them through a combination of spot, commercial pooling, and time-charter arrangements. The majority of its revenue is generated from spot voyages, which typically last less than three months.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: